2-Chloro-4-methoxy-5-nitropyrimidine, 95.0%, 250mg

2,2',3,3'-Tetrahydro-1,1'-spirobi[indene]-7,7'-diol, 95.0%, 5g

3-bromo-5-ethyl-1,2,4-oxadiazole, 95.0%, 1g

1-Methyl-3-(4-sulfobutyl)imidazolium Bis(trifluoromethanesulfonyl)imide>95.0%(T)1g

5-Isopropyl-1H-pyrazole, 95.0%, 10g

1,4-Dihydro-4-oxoquinoline-3-carboxylic Acid>98.0%(HPLC)(T)5g

(5-(Methoxycarbonyl)thiophen-3-yl)boronic acid, 95.0%, 10g

N-(6-Bromopyridin-2-yl)-N-methylacetamide, 95.0%, 1g

4-[(4-Isopropoxyphenyl)sulfonyl]phenol>98.0%(GC)25g

E-plan EPLi 4x/0.10 IOS infinity corrected objective

Heptyl 4-Hydroxybenzoate>98.0%(HPLC)(T)25g

Polyethylene Glycol Monostearate (n=approx. 45) (palmitate and stearate mixture)500g

7-Bromo-1,3,4,5-tetrahydro-1-methyl-2H-1-benzazepin-2-one, 250mg